Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902602015
Pharmaceuticals
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 129M 116M 108M 98.05M 185M 12.53B 186M 1.3B 507M 6.37B 486M 476M 20.48B | P/E 2026 * |
-0.77x | P/E 2027 * | -1.14x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 116M 108M 98.05M 185M 12.53B 186M 1.3B 507M 6.37B 486M 476M 20.48B | EV / Sales 2026 * |
2.35x | EV / Sales 2027 * | 1.17x |
| Free-Float |
99.84% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| +2.92% | +3.12% | +24.78% | +45.10% | 345B | |
| +2.42% | +0.05% | +14.13% | +35.80% | 274B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | +1.46% | -0.48% | +28.56% | +59.87% | 420.89B | |
| Weighted average by Cap. | +0.81% | +0.04% | +32.00% | +70.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 55M 49.15M 45.85M 41.65M 78.44M 5.32B 79.02M 551M 215M 2.71B 206M 202M 8.7B | 111M 99.08M 92.44M 83.96M 158M 10.73B 159M 1.11B 434M 5.46B 416M 407M 17.54B |
| Net income | -169M -151M -141M -128M -241M -16.32B -242M -1.69B -660M -8.3B -633M -620M -26.69B | -164M -147M -137M -124M -234M -15.89B -236M -1.65B -643M -8.08B -617M -603M -25.98B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
